Alcon & STAAR leap on CMS ruling

Article

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

Similar to the CMS decision allowing cataract patients access to presbyopia-correcting IOLs, this new ruling will allow patients to pay the additional charges for the correction of pre-existing astigmatism while Medicare will provide customary reimbursement for the cataract surgery.

Both Alcon and STAAR Surgical believe that their Toric lenses (AcrySof Toric IOL, Alcon; STAAR Toric IOL, STAAR) will be included under this ruling. Such lenses allow a surgeon to replace the cataract lens and provide refractive correction for the astigmatic cornea in a single procedure.

Related Videos
A screenshot of Dr Filomena Ribeiro, president of the ESCRS
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.